Back to search

Sweden· SE-20010629000101

Ceretec Stabilised 0,50 mg Beredningssats för radioaktivt läkemedel

A medicinal product containing exametazime, registered in Sweden by GE Healthcare AS.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedCeretec Stabilised 0,50 mg Berednings…ATC—REGISTER NO.SE-20010629000101PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Exametazime
Manufacturer
GE Healthcare AS
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20010629000101

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Exametazime in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exametazime products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Medi-Exametazim
  • Belgium · Exametazime Radiopharmacy Laboratory, Stabilised Ceretec
  • Czechia · Brain - Spect Kit, Exametazim Radiopharmacy Laboratorium
  • Germany · Medi-Exametazim
  • Denmark · Ceretec, Medi-Exametazim
  • Spain · Ceretec, Ceretec Estabilizado
  • Finland · Ceretec
  • France · Cerestab, Ceretec
  • United Kingdom (Northern Ireland) · Ceretec, Stabilised Ceretec
  • Greece · Ceretec
  • Hungary · Brain-Spect, Ceretec
  • Italy · Ceretec, Exametascan
  • Lithuania · Ceretec
  • Luxembourg · Medi-Exametazim, Stabilised Ceretec
  • Netherlands · Ceretec, Exametazime Radiopharmacy Laboratory
  • Norway · Ceretec, Exametazime Radiopharmacy Laboratory
  • Portugal · Exametazima Radiopharmacy
  • Slovenia · Eksametazim Radiopharmacy Laboratory
  • Slovakia · Ceretec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/601bb0a2-768d-47ee-b8dc-494b29a66841
GET /v1/drugs/601bb0a2-768d-47ee-b8dc-494b29a66841?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20010629000101",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20010629000101",
  "product_doc_link": "https://docetp.mpa.se/LMF/Ceretec%20Stabilised%20kit%20for%20radiopharm%20preparation%20SmPC_09001bee807a21f7.pdf"
}

See everything about exametazime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.